A pack of 5 detailed SOP templates for your clinical trial site during the Coronavirus (COVID-19) Outbreak.
SOP Templates for Clinical Research Sites During Coronavirus
Download![](https://clinicalresearch.io/app/uploads/2023/05/5-Covid-19-SOPs-for-clinical-trial-sites-617x459.png)
![](https://clinicalresearch.io/app/uploads/2023/05/5-Covid-19-SOPs-for-clinical-trial-sites-617x459.png)
![Tech Driven Trials Revolutionizing Patient Centric Design](https://clinicalresearch.io/app/uploads/2024/11/Tech-Driven-Trials-Revolutionizing-Patient-Centric-Design-878x459.png)
Tech-Driven Trials: Revolutionizing Patient-Centric Design
Our latest white paper, Tech-Driven Trials: Revolutionizing Patient-Centric Design, co-authored by industry leaders Dr. Diana Foster, Bruce Hellman, Raymond Nomizu, Hannah Kulkarni, and Sophie Tahiri is now available! This white paper highlights the groundbreaking efforts to embed diversity and inclusion across all phases of clinical research. The Technology Enablement of Diverse Clinical Trials Working Group...
![Clinical Trial Site Mega Network eBook](https://clinicalresearch.io/app/uploads/2023/11/eBook-Winter-23-689x459.png)
The Rise of the Clinical Trial Site Mega Network
Discover our latest eBook, “The Rise of the Clinical Trial Site Mega Network” the third installment in our “Scaling and Innovating” series. The first book in this series was published in 2019, where CRIO predicted that clinical research site networks would continue to grow and consolidate the industry. The second eBook, which was published in...
![A Comparison of EMR and eSource in Clinical Research Trials](https://clinicalresearch.io/app/uploads/2023/05/emr-to-edc-inaccuracies--689x459.jpg)
A Comparison of EMR and eSource Data
In a comparison of EMR and eSource data, we analyzed the medications and medical history documented in the EMR versus the EDC of subjects in active ongoing clinical research studies. The goal was to assess the validity of the assumption of the utility of using EMR data directly. The present study reveals a significant data...